• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对tau蛋白激酶I/糖原合酶激酶3β中核苷酸识别的结构洞察。

Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta.

作者信息

Aoki Masaaki, Yokota Takehiro, Sugiura Ikuko, Sasaki Chizuko, Hasegawa Tsukasa, Okumura Chieko, Ishiguro Koichi, Kohno Toshiyuki, Sugio Shigetoshi, Matsuzaki Takao

机构信息

Mitsubishi Kagaku Institute of Life Sciences (MITILS), 11 Minamiohya, Machida, Tokyo 194-8511, Japan.

出版信息

Acta Crystallogr D Biol Crystallogr. 2004 Mar;60(Pt 3):439-46. doi: 10.1107/S090744490302938X. Epub 2004 Feb 25.

DOI:10.1107/S090744490302938X
PMID:14993667
Abstract

Human tau-protein kinase I (TPK I; also known as glycogen synthase kinase 3 beta; GSK3 beta) is a serine/threonine protein kinase that participates in Alzheimer's disease. Here, binary complex structures of full-length TPK I/GSK3 beta with the ATP analogues ADP and AMPPNP solved by the X-ray diffraction method at 2.1 and 1.8 A resolution, respectively, are reported. TPK I/GSK3 beta is composed of three domains: an N-terminal domain consisting of a closed beta-barrel structure, a C-terminal domain containing a 'kinase fold' structure and a small extra-domain subsequent to the C-terminal domain. The catalytic site is between the two major domains and has an ATP-analogue molecule in its ATP-binding site. The adenine ring is buried in the hydrophobic pocket and interacts specifically with the main-chain atoms of the hinge loop. The overall structure and substrate-binding residues are similar to those observed in other Ser/Thr protein kinases, while Arg141 (which is not conserved among other Ser/Thr protein kinases) is one of the key residues for specific ATP/ADP recognition by TPK I/GSK3 beta. No residues are phosphorylated, while the orientation of the activation loop in TPK I/GSK3 beta is similar to that in phosphorylated CDK2 and ERK2, suggesting that TPK I/GSK3 beta falls into a conformation that enables it to be constitutively active.

摘要

人tau蛋白激酶I(TPK I;也称为糖原合酶激酶3β;GSK3β)是一种参与阿尔茨海默病的丝氨酸/苏氨酸蛋白激酶。本文报道了分别通过X射线衍射法在2.1 Å和1.8 Å分辨率下解析的全长TPK I/GSK3β与ATP类似物ADP和AMPPNP的二元复合物结构。TPK I/GSK3β由三个结构域组成:一个由封闭的β桶结构组成的N端结构域、一个包含“激酶折叠”结构的C端结构域以及C端结构域之后的一个小的额外结构域。催化位点位于两个主要结构域之间,其ATP结合位点中有一个ATP类似物分子。腺嘌呤环埋在疏水口袋中,并与铰链环的主链原子特异性相互作用。整体结构和底物结合残基与其他丝氨酸/苏氨酸蛋白激酶中观察到的相似,而Arg141(在其他丝氨酸/苏氨酸蛋白激酶中不保守)是TPK I/GSK3β特异性识别ATP/ADP的关键残基之一。没有残基被磷酸化,而TPK I/GSK3β中激活环的取向与磷酸化的CDK2和ERK2中的相似,这表明TPK I/GSK3β处于一种使其能够组成性激活的构象。

相似文献

1
Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta.对tau蛋白激酶I/糖原合酶激酶3β中核苷酸识别的结构洞察。
Acta Crystallogr D Biol Crystallogr. 2004 Mar;60(Pt 3):439-46. doi: 10.1107/S090744490302938X. Epub 2004 Feb 25.
2
Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.与GSK3肽和AMP-PNP形成的活化Akt/蛋白激酶B三元复合物的晶体结构。
Nat Struct Biol. 2002 Dec;9(12):940-4. doi: 10.1038/nsb870.
3
Homology modeling and molecular dynamics study of GSK3/SHAGGY-like kinase.糖原合成酶激酶3/类SHAGGY激酶的同源建模与分子动力学研究
Comput Biol Chem. 2004 Jul;28(3):179-88. doi: 10.1016/j.compbiolchem.2004.02.003.
4
Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product.磷酸化酶激酶催化结构域的两种结构:一种与底物类似物和产物复合的活性蛋白激酶。
Structure. 1995 May 15;3(5):467-82. doi: 10.1016/s0969-2126(01)00180-0.
5
Structures of human MST3 kinase in complex with adenine, ADP and Mn2+.人源MST3激酶与腺嘌呤、ADP和Mn2+结合的结构。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):145-54. doi: 10.1107/S0907444909047507. Epub 2010 Jan 22.
6
Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.与肽抑制剂PKI(5 - 24)和腺苷复合的环磷酸腺苷依赖性蛋白激酶的多组氨酸标签重组催化亚基的晶体结构。
Biochemistry. 1997 Apr 15;36(15):4438-48. doi: 10.1021/bi961947+.
7
GTP plus water mimic ATP in the active site of protein kinase CK2.在蛋白激酶CK2的活性位点中,鸟苷三磷酸(GTP)加水可模拟三磷酸腺苷(ATP)。
Nat Struct Biol. 1999 Dec;6(12):1100-3. doi: 10.1038/70033.
8
Crystal structure of heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) and the inhibitory influence of citrate on substrate binding.心脏6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶(PFKFB2)的晶体结构以及柠檬酸对底物结合的抑制作用。
Proteins. 2017 Jan;85(1):117-124. doi: 10.1002/prot.25204. Epub 2016 Nov 29.
9
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.糖原合酶激酶3特异性抑制剂AR-A014418的结构见解与生物学效应
J Biol Chem. 2003 Nov 14;278(46):45937-45. doi: 10.1074/jbc.M306268200. Epub 2003 Aug 19.
10
Structural basis for the complete loss of GSK3beta catalytic activity due to R96 mutation investigated by molecular dynamics study.通过分子动力学研究探究R96突变导致GSK3β催化活性完全丧失的结构基础。
Proteins. 2009 May 15;75(3):671-81. doi: 10.1002/prot.22279.

引用本文的文献

1
Computational discovery of ATP-competitive GSK3β inhibitors using database-driven virtual screening and deep learning.利用数据库驱动的虚拟筛选和深度学习进行ATP竞争性GSK3β抑制剂的计算发现
Mol Divers. 2025 Aug 13. doi: 10.1007/s11030-025-11320-5.
2
Integrative machine learning and molecular simulation approaches identify GSK3β inhibitors for neurodegenerative disease therapy.整合机器学习和分子模拟方法鉴定用于神经退行性疾病治疗的糖原合成酶激酶3β抑制剂。
Sci Rep. 2025 Jul 1;15(1):21632. doi: 10.1038/s41598-025-04129-7.
3
Alzheimer's Disease and Cancer: Common Targets.
阿尔茨海默病与癌症:共同靶点
Mini Rev Med Chem. 2024;24(10):983-1000. doi: 10.2174/0113895575263108231031132404.
4
Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders.基于药效团的筛选、分子对接和真菌代谢产物作为神经退行性疾病多靶点抑制剂的动态模拟。
Biomolecules. 2023 Nov 4;13(11):1613. doi: 10.3390/biom13111613.
5
Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer's Disease.针对糖原合成酶激酶3β、N-甲基-D-天冬氨酸受体和β-分泌酶1的天然产物类化合物的多靶点虚拟筛选及分子模拟用于阿尔茨海默病的治疗
Pharmaceuticals (Basel). 2023 Apr 20;16(4):622. doi: 10.3390/ph16040622.
6
Synthesis and Antiplasmodial Activity of Bisindolylcyclobutenediones.双吲哚环丁烯二酮的合成及抗疟活性。
Molecules. 2021 Aug 5;26(16):4739. doi: 10.3390/molecules26164739.
7
High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer's disease using computational approaches.利用计算方法对天然化合物进行高通量筛选并抑制阿尔茨海默病的主要治疗靶点HsGSK-3β
J Genet Eng Biotechnol. 2021 May 4;19(1):61. doi: 10.1186/s43141-021-00163-w.
8
Perfluorooctanoic acid impaired glucose homeostasis through affecting adipose AKT pathway.全氟辛酸通过影响脂肪组织中的AKT信号通路损害葡萄糖稳态。
Cytotechnology. 2018 Feb;70(1):479-487. doi: 10.1007/s10616-017-0164-6. Epub 2018 Jan 16.
9
Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities study.GSK-3β和CDK5双重抑制剂的设计:虚拟筛选与体外生物学活性研究
Oncotarget. 2017 Mar 14;8(11):18118-18128. doi: 10.18632/oncotarget.15085.
10
Molecular features of product release for the PKA catalytic cycle.蛋白激酶A催化循环中产物释放的分子特征。
Biochemistry. 2015 Jan 13;54(1):2-10. doi: 10.1021/bi500684c. Epub 2014 Aug 8.